IAPP and Alzheimer disease: Our results show that short sequence peptide fragments (Fig. 6), which are derived from the amylin antagonist, AC253, retain the antagonist activities of the parent peptide, are neuroprotective against Aβ toxicity in cell culture paradigms and improve hippocampal LTP in transgenic AD mice.